Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational Approaches

Mohd Rehan1,2, Ummer R Zargar3, Ishfaq A Sheikh2,4

  • 1King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Toxics
|December 22, 2022
PubMed

Insights

Nicotine and its metabolites bind to hormone carrier proteins, potentially disrupting hormone balance. This study reveals how these compounds interfere with sex hormone-binding globulin, corticosteroid-binding globulin, and thyroxine-binding globulin.

Area of Science:

  • Endocrinology
  • Toxicology
  • Molecular Biology

Background:

  • Tobacco/nicotine is a major public health threat due to its toxicity and addictive nature.
  • Nicotine disrupts endocrine homeostasis, affecting gonadal, adrenal, and thyroid hormones.
  • Understanding nicotine's interaction with hormone transport is crucial for public health.

Purpose of the Study:

  • To characterize the structural binding interactions of nicotine and its metabolites (cotinine, trans-3'-hydroxycotinine, 5'-hydroxycotinine) with key hormone carrier proteins.
  • To identify specific amino acid residues involved in these interactions.
  • To elucidate the potential impact on hormone transport and homeostasis.

Main Methods:

  • Computational analysis of binding interactions between nicotine/metabolites and carrier proteins (SHBG, CBG, TBG).
  • Identification of key amino acid residues through analysis of nonbonded contacts and hydrogen bonds.
  • Assessment of the impact on accessible surface area (ASA) upon ligand binding.

Main Results:

  • Nicotine and its metabolites form nonbonded contacts and hydrogen bonds with SHBG, CBG, and TBG.
  • Specific residues like Phe-67 and Met-139 (SHBG), Trp-371 and Asn-264 (CBG), and Ser-23, Leu-269, Lys-270, Asn-273, Arg-381 (TBG) are critical for binding.
  • Interacting residues often overlap with those for native hormone ligands, suggesting competitive binding.

Conclusions:

  • Nicotine and its metabolites compete with native ligands for binding to SHBG, CBG, and TBG.
  • This competition may lead to the disbalance of testosterone, estradiol, cortisol, progesterone, thyroxine, and triiodothyronine transport and homeostasis.
  • The findings highlight a potential mechanism for nicotine's adverse endocrine effects.

Related Concept Videos

Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
3.4K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.2K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K